ALNAQ — Allena Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$1.68m
Annual cashflow statement for Allena Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -21.6 | -35.6 | -47.3 | -32.8 | -48.7 |
| Depreciation | |||||
| Non-Cash Items | 1.16 | 2.83 | 3.48 | 4.68 | 4.11 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.646 | 0.904 | 0.061 | -0.159 | -1.48 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -21.1 | -31.8 | -43.6 | -28.2 | -45.7 |
| Capital Expenditures | -0.057 | -0.318 | -0.122 | -0.65 | -0.667 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 23.5 | 0 | 0 | 0.018 | 0 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 23.4 | -0.318 | -0.122 | -0.632 | -0.667 |
| Financing Cash Flow Items | 0 | -0.066 | -0.029 | -0.238 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 66.9 | -0.694 | 12.1 | 33.8 | 41.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 69.2 | -32.9 | -31.6 | 5.04 | -5.05 |